tm logo

Monitor this mark

View On USPTO

BOXABAN
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 21 Sep 2021

Last Applicant/ Owned by

Cumberland Pharmaceuticals Inc.

1600 West End Ave

Nashville

TN

37203

Serial Number

85624288 filed on 14th May 2012

Registration Number

4752220 registered on 09th Jun 2015

in the Principal Register

Correspondent Address

Kristina Montanaro Schrader

Kristina Montanaro Schrader Adams and Reese LLP

Suite 1400

Nashville, TN 37203

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

BOXABAN

Pharmaceutical preparations for use in patients with pulmonary hypertension and in patients with Peripheral Artery Disease

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for use in patients with pulmonary hypertension and in patients with Peripheral Artery Disease

First Use Date in General

15th Apr 2015

First Use Date in Commerce

15th Apr 2015

Mark Details

Serial Number

No 85624288

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 604816-23

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
10th Jun 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
16th Jan 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16th Jan 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16th Jan 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
16th Jan 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
16th Jan 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22nd Apr 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22nd Apr 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22nd Apr 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
21st Sep 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED